All News
No Extra Cancer Recurrence Risk Seen for RA Patients on Biologic Therapy
(MedPage Today) -- Rheumatoid arthritis (RA) patients in Denmark with a history of solid tumor cancers, now in remission, faced no greater likelihood of cancer relapse when they were treated with bio
Read MoreAntibiotic Candidate for Lyme Disease Boosts Hope for Custom Approach
(MedPage Today) -- In the realm of Lyme disease research, one antibiotic emerged as being highly effective for treatment of acute infection, and early-stage data lent credence to one theory for the p
Read MoreBTK Inhibitors for Follicular Lymphoma
(MedPage Today) -- Newer-generation Bruton's tyrosine kinase (BTK) inhibitors have found a place in the management of follicular lymphoma, a malignancy where the first-generation drug ibrutinib (Imbr
Read MoreWhat Physicians Can Learn From Pope Francis
(MedPage Today) -- Catholics and Christians worldwide, as well as non-religious people, are mourning the death of Pope Francis, who is often referred to as the "People's Pope.
Read MoreStudies zoom in on clues to why Lyme disease persists and which antibiotic to prescribe
A new study on Lyme disease sheds light on the persistence of symptoms; another new study points to an antibiotic that may be more effective.
Read MoreColdplay Singer's Depression; Add-On Cobenfy Flopped; Uptick in Psilocybin Use
(MedPage Today) -- Coldplay singer Chris Martin shared his strategies for managing depression with Vanity Fair.
Read MoreNovavax Says Its COVID Shot Is on Track for Full FDA Approval After Delay
(MedPage Today) -- Novavax's closely watched COVID-19 vaccine is on track for full approval after additional discussions with the FDA, the company said Wednesday.
Read MoreAnti-Vaxxers Say Bioweapon Caused Measles Outbreak; DOGE Holds Health Grants Hostage
(MedPage Today) -- Welcome to the latest edition of Investigative Roundup, highlighting some of the best investigative reporting on healthcare each week.
Read MoreSTAT+: Former Trump official warns president he’s at risk of ruining his legacy on ending HIV
DOGE's funding cuts threaten to undo progress toward curbing HIV, a former top Trump official warned.
Read MoreHigh Response Rate in Myeloma With Novel CAR-T After Anti-BCMA Failure
(MedPage Today) -- More than 80% of patients whose multiple myeloma had progressed on standard chimeric antigen receptor (CAR) T-cell therapy responded to an investigational CAR T-cell agent, a small
Read More